Search for: "Pfizer, Inc."
Results 1421 - 1440
of 1,513
Sorted by Relevance
|
Sort by Date
17 Mar 2009, 12:50 pm
This warning procedure was outlined in Est’ee Lauder, Inc. v. [read post]
7 Apr 2008, 2:56 pm
According to Gregg Engles, former lawyer and current CEO of Dean Foods, Inc., the discrepancy is simple. [4] "Many lawyers let knowledge of risk paralyze them. [read post]
28 Oct 2011, 7:00 am
Pfizer, Inc., 358 F.3d 659, 661 (9th Cir. 2004) (“the doctor who prescribed [the drug] . . . failed to read [the defendant’s] published warnings before prescribing the drug. [read post]
20 Jun 2008, 8:07 am
: (IP finance), Technical assistance a key point of discussion at TRIPS Council: (Intellectual Property Watch), WIPO turmoil as new DG’s future comes under threat: (IAM), WIPO to host inter-regional forum to explore strategies to enhance development and service-orientation of IP offices: (WIPO), Controversy over lack of transparency and overreaching enforcement provisions in ACTA: (Spicy IP), (Spicy IP) Global - Trade Marks / Domain Names / Brands World anti-counterfeiting day:… [read post]
5 Jul 2008, 11:05 am
: (IP tango), China: Pfizer loses trade mark action against Jaingsu Lianhuan Pharmaceutical Co over 3D mark: (Rouse & Co International), India: More patents for new forms issued to generics: (Patent Circle), India: Gauri Kamath on drug ‘differential pricing’ in India: (Spicy IP), Mexico: Revised health supplies regulations promise changes for generics: (International Law Office), US: World drug pricing crisis: Congressmen criticise US Trade Representative over… [read post]
3 Sep 2009, 1:24 am
Ropes & Gray Leads on Pfizer's Record $2.3 Billion Settlement
The American Lawyer
Ropes & Gray took the lead among several firms in advising Pfizer on its decision Wednesday to pay $2.3 billion in fines and penalties to settle charges it illegally marketed several drugs for off-label uses and paid kickbacks to doctors, according to lawyers on the deal. [read post]
26 Jun 2024, 8:30 am
Another example of an FBR case in which incarceration was ordered for conduct that was as or less serious compared with Trump’s case: Pfizer Inc. [read post]
28 Nov 2012, 4:47 pm
Manufactured by Pfizer, Inc. [read post]
11 Apr 2014, 7:41 am
STERN v. [read post]
22 May 2014, 5:00 am
Pfizer, Inc., 2000 WL 1099884, at *2 & n.1 (S.D.N.Y. [read post]
27 Feb 2014, 6:00 am
We watched some of the recently concluded Winter Olympics. [read post]
24 Nov 2015, 12:38 pm
Pfizer, Inc., 712 F.3d 21 (1st Cir. 2013), and the rest of the First Circuit’s Neurontin trilogy, which took the top spot in our list of worst decisions of 2013. [read post]
25 Apr 2015, 11:03 am
The first edition of the Reference Manual on Scientific Evidence [Manual] was published in 1994, a year after the Supreme Court delivered its opinion in Daubert. [read post]
20 May 2010, 12:46 pm
Pfizer, Inc., 490 F. [read post]
22 Feb 2008, 6:00 pm
Signature Financial Group, Inc., and AT&T Corp. v. [read post]
8 Jul 2012, 10:58 am
.); In re Pfizer Inc. [read post]
19 Apr 2013, 5:35 pm
Inc., 2012 U.S. [read post]
16 Aug 2009, 9:51 pm
In arguing their motion, Microsoft unfortunately relied on Schering Corp v Pfizer (1999) where, although the Court had excluded five surveys from evidence under the hearsay rule, the Court did not discuss Rule 703 save to say, damagingly for Microsoft, that it was an acceptable basis to admit survey evidence. [read post]
4 Apr 2008, 1:00 am
: (IPBiz) Pharma & Biotech - Products Abilify (Aripiprazole) – Otsuka files US patent infringement suit against Teva over seeking approval for generic Abilify: (IP Law360), Aricept (Donepezil) – US federal judge grants Eisai’s request for preliminary injunction blocking Teva from marketing generic version of Aricept: (IP Law360), (Orange Book Blog), Carbatrol (Carbamazepine) – US federal judge delivers mixed ruling in Shire… [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
